<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
<channel>
  <title>Bill Analysis - GOP.gov</title>
  <link>http://www.gop.gov/</link>
  <description>Bill Analysis from Republicans in Congress</description>
  <language>en-US</language>
  <lastBuildDate>Monday, March 15, 2010</lastBuildDate>
  <pubDate>Monday, March 15, 2010</pubDate>
      <item>
        <title>H.R. 3276: American Medical Isotopes Production Act of 2009</title>
        <keywords>committee on energy and commerce</keywords>
        <link>http://www.gop.gov/bill/111/1/hr3276</link>
        <description><![CDATA[<strong>Rep. Markey, Edward J. | Committee on Energy and Commerce</strong> <p>H.R. 3276 would authorize funding to support projects to produce molybdenum-99, a radioactive isotope used in certain medical procedures.</p><p>Specifically, the bill authorizes $163 million in Fiscal Years 2011 through 2014 for the Department of Energy to establish a program to evaluate and support projects for production in the U.S., without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses.  The legislation also directs the Department to make low enriched uranium (LEU) available through lease contracts to producers of molybdenum-99.  The contracts would allow the Department to retain financial responsibility for radioactive waste generated by the irradiation, processing, or purification of LEU.</p><p>&nbsp;</p>]]></description>
      </item>
	 
      <item>
        <title>H.R. 3276: American Medical Isotopes Production Act of 2009</title>
        <keywords>committee on energy and commerce</keywords>
        <link>http://www.gop.gov/bill/111/1/hr3276</link>
        <description><![CDATA[<strong>Rep. Markey, Edward J. | Committee on Energy and Commerce</strong> <p>H.R. 3276 would authorize funding to support projects to produce molybdenum-99, a radioactive isotope used in certain medical procedures.</p><p>Specifically, the bill authorizes $163 million in Fiscal Years 2011 through 2014 for the Department of Energy to establish a program to evaluate and support projects for production in the U.S., without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses.  The legislation also directs the Department to make low enriched uranium (LEU) available through lease contracts to producers of molybdenum-99.  The contracts would allow the Department to retain financial responsibility for radioactive waste generated by the irradiation, processing, or purification of LEU.</p><p>&nbsp;</p>]]></description>
      </item>
	 
   </channel>
  </rss>
